Meghan Carr
Psychiatric/Mental Health · Cranford, NJNPI 1588271647
Payments from drug & device makers
What this record shows
AbbVie accounts for 81.0% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $2,806, 4.1 times the $692 reported in 2021. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $34.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Takeda Pharmaceuticals U.S.A., Inc.$205
- Otsuka America Pharmaceutical, Inc.$187
- Johnson & Johnson$139
- Lundbeck LLC$109
- Corium, LLC$108
- plus $512 from 11 others
What the payments were for
- Speaking & faculty fees$3,75057%
- Food & beverage$2,87443%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 104 | $5,365 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $205 |
| Otsuka America Pharmaceutical, Inc. | 15 | $187 |
| Johnson & Johnson | 3 | $139 |
| Lundbeck LLC | 8 | $109 |
| Corium, LLC | 8 | $108 |
| Sunovion Pharmaceuticals Inc. | 8 | $101 |
| Neurocrine Biosciences, Inc. | 6 | $79 |
| Almatica Pharma LLC | 4 | $56 |
| Alkermes, Inc. | 4 | $55 |
| Teva Pharmaceuticals USA, Inc. | 4 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $41 |
| Vanda Pharmaceuticals Inc. | 3 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Alfasigma USA, Inc. | 2 | $28 |
| Bausch Health US, LLC | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,624 in reported general payments places this provider in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 24 | $1,404 |
| Clonazepam | 41 | $783 |
| Mirtazapine | 26 | $562 |
| Duloxetine Hcl | 22 | $537 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $475 |
| Bupropion XlBupropion Hcl | 13 | $409 |
| Lamotrigine | 13 | $328 |
| Trazodone Hcl | 18 | $208 |
| Alprazolam | 40 | $182 |
| Sertraline Hcl | 17 | $167 |
| Fluoxetine Hcl | 13 | $156 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $56 | $16717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Other psychiatric/mental health in Cranford
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
- Marisa SavicOradel$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.